India’s drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, Reuters reported.
The approval could help health authorities minimise vaccine wastage and better plan their inoculation programmes.
AstraZeneca said in a statement that its product could be stored, transported and handled at normal refrigerated conditions for at least six months. The World Health Organization website also gives the shelf-life of Covishield and the South Korean-made AstraZeneca shot as six months.
